CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy Demand for pharmacy care is high, with 76% of consumers having at least one prescription for themselves or a person they care forMost consumers (81%) say they trust their local pharmacist and 83% say their pharmacist's recommendations are important to them WOONSOCKET, R.I., Oct. 15, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released the Rx Report: T ...

WOONSOCKET, R.I., Oct. 8, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for Hurricane Milton's landfall in Florida tomorrow. The company's priority is the health and safety of its customers, members and colleagues, and it is committed to providing communities with access to the products and services they need to plan for the storm.CVS Pharmacy® is reaching out to its patients by text message, email and phone to remind them to refill and pick up prescriptions. Stores are also receiving a ...

WOONSOCKET, R.I., Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss third quarter 2024 financial results.An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.CVS Health logo (PRNewsFoto/CVS Health)About CVS HealthCVS Health® is the leading heal ...

Major changes could soon be coming, but will they drive the stock up?With rumors swirling about CVS Health's (CVS 2.65%) new and ongoing discussions on how to turn around the company's sagging fortunes, it's natural for investors to wonder whether there's a new flurry of risks on the way, or there are whiffs of fresh opportunity in the air.Management's final plan doesn't appear to be wrapped up just yet, but analyzing the challenges faced by the business -- as well as the actions that it's already taking -- ...

The stock could be poised for a turnaround.Billionaire investor Larry Robbins of hedge fund Glenview Capital Management has taken a large stake in healthcare company CVS Health (CVS 2.65%) and has met with management on ways to help turn around the struggling business. According to The Wall Street Journal, Glenview has amassed about a $700 million stake in the company. Meanwhile, according to CNBC, CVS has met with advisors to conduct a strategic review of its business. The review started before Glenview be ...

We also chat about Uber and its quest to become an everything app. In this podcast, Motley Fool analyst Seth Jayson and host Dylan Lewis discuss: Why CVS has activists sniffing around, and how getting the insurance operations right could get the company and the stock back in motion. How interest rates are affecting the housing and auto markets, and other updates from KB Homes and CarMax. Motley Fool analyst Jason Moser and host Mary Long look at Uber, and its quest to become the everything app. To catch ful ...

Shares of CVS Health Corp (NYSE:CVS) are 3.9% higher to trade at $65.40 at last glance, after several updates for the healthcare giant. According to reports, CVS' insurance unit is facing higher-than-usual medical costs and other major issues. In response, the company is conducting a strategic review, and considering shifting from its long-held business strategy by splitting its retail pharmacy and insurance units. Amid this big news, TD Cowen upgraded CVS Health stock to "buy" from "hold" and hiked its tar ...

In this article CVS A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. Joe Raedle | Getty Images It's time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy reimbursement pressure, among other issues. As it seeks to claw back faith with Wall Street, the company is considering breaking itself up. CVS has engaged advisors in a strategic review of its bu ...

The most recent trading session ended with CVS Health (CVS) standing at $62.92, reflecting a +1.09% shift from the previouse trading day's closing. The stock's change was more than the S&P 500's daily loss of 0.17%. Elsewhere, the Dow saw a downswing of 0.44%, while the tech-heavy Nasdaq depreciated by 0.04%.Shares of the drugstore chain and pharmacy benefits manager witnessed a gain of 4.96% over the previous month, trailing the performance of the Retail-Wholesale sector with its gain of 5.43% and outperfo ...

CVS Health (CVS) is mired in controversy these days. The company has been struggling with its performance for a while now, which resulted in a downside in shares. The company is once again in the headlines as it is reportedly considering a strategic restructuring of the business, which includes possible layoffs and potential breakups. More specifically, earlier this week, news surfaced that the company might consider a disintegration of its verticals, which perhaps means divestment/spin-off of its Caremark ...